Arisaph Pharmaceuticals
is a biopharmaceutical company, focuses on developing therapies for cancer and cardiovascular disease... Read moreArisaph Pharmaceuticals
is a biopharmaceutical company, focuses on developing therapies for cancer and cardiovascular disease... Read more
News
Apr 05, 2016
Newswire
Press Release: Arisaph Pharmaceuticals : DPP IV Inhibitors Market: Some Leading Market Players are Arisaph Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Eli Lilly And Company and Others
Apr 01, 2016
NewsMaker
Press Release: Arisaph Pharmaceuticals :
Non Alcoholic Fatty Liver Disease (NAFLD) Therapeutics & Drugs Pipeline Review, H1 2016
Sep 08, 2015
BUSINESS WIRE
Press Release: Arisaph Pharmaceuticals : Research and Markets: Global Non Alcoholic Fatty Liver Disease (NAFLD) Pipeline Review 2015 - 18 Companies & 29 Drug Profiles
May 29, 2015
PR-INSIDE.COM
Press Release: Arisaph Pharmaceuticals : New Report Available: Arisaph Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
May 19, 2015
PRSYNC
Press Release: Arisaph Pharmaceuticals : Arisaph Pharmaceuticals, Inc. - Product Pipeline Review - Market Research Report 2015
Sep 29, 2014
BIOSPACE
Arisaph Pharmaceuticals: Arisaph Pharmaceuticals, Inc. Awarded Supplemental Phase I And Phase 2 STTR Grants To Develop Oncology Drug Candidates
Sep 29, 2014
PR NEWSWIRE
Press Release: Arisaph Pharmaceuticals : Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates
Aug 19, 2014
BUSINESS WIRE
Press Release: Arisaph Pharmaceuticals : Research and Markets: Competitor Analysis: GLP-1 Receptor Agonists Development Pipeline Report 2014
Arisaph Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9